Case Study: Dramatic Regression of Cavernoma in the Brain

Submitted by: NVLife Pvt. Ltd. | Naveen Varshneya, Founder

Startup India Certificate No.:DIPP115867

Client Profile

Age: 43 years
Condition: Cavernoma in the left parietal lobe of the brain with haemorrhagic lesion and mild mass effect.
Risk Severity: High — cavernomas carry risk of repeated haemorrhage, seizures, neurological deficits, and can be life-threatening.

Medical History

Initial MRI (Apr–May 2021):

Well-defined ovoid lesion (~3.8 × 3.5 × 3.9 cm) in left parietal lobe.
Hyperintense with peripheral hypointense rim, blooming on SWI, diffusion restriction.
Surrounding oedema and indentation of left lateral ventricle.

Diagnosis: Subacute intraparenchymal haematoma linked to cavernoma/small AVM.
Clinical Outlook: Considered a neurosurgical case with potential long-term disability or mortality if condition worsened.

Presenting State (Before NV Life)

Entered NV Life’s Treatment Program while in a state of extreme illness.
Struggled with debilitating fears (death, failure, being judged).
Emotionally unstable; relationships and professional life deeply strained.
At risk of invasive brain surgery

Intervention: NV Life Science Techniques

Practices Applied:

Observing the Breath (OTB) for grounding fear and stabilising emotional states.
Yog Nidra (deep meditative state) spontaneously accessed during OTB.
Hunting to uncover subconscious emotional patterns driving illness.

Guidance:

Intensive 90-day program with support from NV Life faculty and coach Tulika.
Directed to face patterns of suppressed shame, anger, and “revenge tendency” rooted in parental judgements.

Treatment Experience

First 12 Days: Rapid relief from fear, entry into Yog Nidra, felt anchored.
First 30 Days:

Major transformation at work — authenticity, trust, honesty in relationships.
Improved bond with mother.

Next 40 Days: Hit stagnation; intense resistance to confronting sexuality, dark, fantasy. Arrogance from early progress created setbacks.
Final Weeks: Breakthrough realisation: Breakthrough realisation: lifelong revenge pattern driven by shame and anger. Acceptance dissolved inner conflict and allowed deep healing.

Results Achieved (Clinical Evidence)

MRI Findings:

May 28, 2021: Lesion measured 3.98 × 4.22 cm
Aug 18, 2021: Reduced to 1.8 × 2.18 cm (~70% shrinkage)

Doctors’ Analysis:

“Magnificent results — surgery no longer required.”
Cavernoma may vanish or become insignificant.
Medicines to be tapered; next MRI scheduled Feb 2022.

Functional Recovery:

Energy and sleep improved.
Emotional stability and resilience gained.
Restored professional performance with authenticity and confidence.

Medical Plan: Medication dosage reduced; next MRI scheduled in Feb 2022.

Therapeutic Elements

Breath-based practices grounding fear and stress responses.
Yog Nidra facilitating neurophysiological rest and repair.
Hunting uncovering deep-rooted revenge-driven patterns.
Faculty support providing insights that catalysed breakthroughs when resistance peaked.

Client Testimonial

"I am astonished and amazed at the depth of insights and impact coming out of NV Life. This journey has just started, and I feel confident using these simple tools to deal with everyday challenges and life events.”

Current Status

Cavernoma significantly regressed, prognosis positive.
No surgery required.
Medicines being tapered under doctor supervision.
Continues NV Life practices daily for ongoing healing.

Timeline

Apr 2021: MRI confirmed large cavernoma with haemorrhage.
May 28, 2021: Lesion at 3.98 × 4.22 cm; surgery being considered.
Jun–Aug 2021: Intensive NV Life program; breakthroughs in emotional healing.
Aug 18, 2021: MRI showed shrinkage to 1.8 × 2.18 cm. Surgery ruled out.
Feb 2022 (planned): Next MRI follow-up scheduled.